Metabolon to Provide Metabolomic Profiling Services to GSK | GenomeWeb

NEW YORK (GenomeWeb) – Metabolon today announced a collaboration to provide metabolomic profiling services to GlaxoSmithKline.

The two firms also will collaborate on research projects using Metabolon's DiscoveryHD4 platform. Financial and other terms of the agreement were not disclosed.

GSK will have access to Metabolon's bioinformatics tools, proprietary disease ontologies, and visualization tools to integrate metabolomics data with existing genomics and proteomics data, Metabolon said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.